KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 124 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $747,000 | -8.1% | 198,730 | 0.0% | 0.02% | -11.5% |
| Q1 2018 | $813,000 | -49.0% | 198,730 | -42.1% | 0.03% | -46.9% |
| Q4 2017 | $1,595,000 | -48.2% | 343,035 | -20.9% | 0.05% | -49.5% |
| Q3 2017 | $3,081,000 | +11.8% | 433,925 | +13.8% | 0.10% | +31.1% |
| Q2 2017 | $2,756,000 | – | 381,205 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 18,300,000 | $258,945,000 | 5.09% |
| EcoR1 Capital, LLC | 589,000 | $8,334,000 | 4.22% |
| Camber Capital Management LP | 3,000,000 | $42,450,000 | 2.82% |
| Cormorant Asset Management, LP | 1,000,000 | $14,150,000 | 2.18% |
| SECTORAL ASSET MANAGEMENT INC | 3,257,358 | $46,092,000 | 2.07% |
| Knoll Capital Management, LLC | 200,000 | $2,830,000 | 1.11% |
| OAK RIDGE INVESTMENTS LLC | 3,247,990 | $45,959,000 | 1.10% |
| NORTHPOINTE CAPITAL LLC | 514,445 | $7,279,000 | 0.87% |
| Apex Capital Management | 1,843,754 | $26,089,000 | 0.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,183,484 | $16,746,000 | 0.60% |